e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Obstructive sleep apnoea in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea
Silke Ryan (Dublin, Ireland)
Source:
International Congress 2015 – Obstructive sleep apnoea in adults and children
Session:
Obstructive sleep apnoea in adults and children
Session type:
Session
Number:
441
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Silke Ryan (Dublin, Ireland). Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea. International Congress 2015 – Obstructive sleep apnoea in adults and children
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert view on treatment approach to children with persistent obstructive sleep apnoea
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Intermittent hypoxia in sleep apnea: a cause of inflammatory activation
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
Source: Eur Respir J 2009; 33: 1195-1205
Year: 2009
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013
Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
A simple device to subject cells to intermittent hypoxia mimicking obstructive sleep apnea
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Ventilatory response amongst patients with obstructive sleep apnoea
Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa
Year: 2016
Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP
Source: Eur Respir J 2005; 26: Suppl. 49, 355s
Year: 2005
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients?
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia
Source: Eur Respir J 2012; 39: 1492-1500
Year: 2012
Mechanisms and assessment of vascular damage in obstructive sleep apnoea
Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea”
Year: 2013
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Source: Eur Respir J 2008; 32: 1082-1095
Year: 2008
Pathophysiology of the upper airway in obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept